Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PEGASUS: PErsonalized Genomics for Prenatal Aneuploidy Screening USing Maternal Blood

NCT01925742 is registered in ClinicalTrials.gov with CHU de Quebec-Universite Laval as lead sponsor.

NCT NCT01925742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01925742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PEGASUS: PErsonalized Genomics for Prenatal Aneuploidy Screening USing Maternal Blood
Lead sponsor
CHU de Quebec-Universite Laval
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2013
Completion date
June 30, 2017
Enrollment
3,819 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

trisomy 13, trisomy 18, trisomy 21